Delivery Order 75N93022D00019-75N93022F00001
Award Date
1/14/22
Potential Completion Date
1/13/32
Potential Value
$2M
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Duke University
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Durham, NC 27708, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
6
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a cost-no-fee Delivery Order contract awarded by the National Institute of Allergy and Infectious Diseases, a civilian agency, to Duke University for a Phase 1 Clinical Trial Unit for Therapeutics Against Infectious Diseases. The contract has a ceiling value of $416,539.69 and a period of performance through August 31, 2017. This order is part of a larger Therapeutics Against Infectious Diseases Phase 1 Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle. No set-aside...
This is a federal contract award to Duke University, a private university and non-profit organization, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) under the U.S. Department of Health and Human Services (HHS). The contract is a Delivery Order under the "Therapeutics Against Infectious Diseases Phase 1" indefinite delivery/indefinite quantity (IDIQ) contract vehicle, with a ceiling value of $212,814.70....
This is a cost-plus-fixed-fee delivery order awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Duke University for a Phase 1 Clinical Trial Unit for Therapeutics Against Infectious Diseases. The potential value of the award is $126,086.19. The order was issued against the Therapeutics Against Infectious Diseases Phase 1 master contract. No set-aside designation was used. As the prime contractor, Duke University will provide clinical...
This federal contract award is for a $109,969 Phase 1 Clinical Trial to be conducted by Duke University Office of Research Administration Division for the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases. The contract is a delivery order against the parent Therapeutics Against Infectious Diseases Phase 1 multiple-award IDIQ contract. Duke University, a private non-profit research university, is the prime...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $115,139.00 delivery order contract to Duke University Office Of Research Administration Division, a private non-profit educational institution, to support a Phase 1 clinical trial unit for therapeutics against infectious diseases. The contract is part of the Therapeutics Against Infectious Diseases Phase 1 master contract vehicle and has a completion date...
This is a federal contract award to Duke University, a private university, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract is part of the Vaccine and Treatment Evaluation Units (VTEU) program, which supports clinical research on vaccines and treatments for infectious diseases. The specific award is for Task B1C1 under contract HHSN272201300017I, with a ceiling value of $1,154,053.22. The award date was...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $138,686 delivery order to Duke University's Office of Research Administration Division for a Phase 1 Clinical Trial Unit for Therapeutics Against Infectious Diseases. The contract has a potential value of $115,875.31 and a completion date of December 14, 2018. This delivery order is part of a larger Therapeutics Against Infectious Diseases Phase 1 indefinite...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Duke University. The award is for $799,872 under the Vaccine and Treatment Evaluation Units (VTEU) program, with a period of performance from September 15, 2015 to July 31, 2020. The award is a delivery order under the VTEU indefinite delivery/indefinite quantity (IDIQ) contract vehicle. No set-aside designation was used for this award. Duke University, a private...
This is a federal contract award to Duke University by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH). The contract, valued at $10,236,804.91, is a Definitive Contract with a Cost Plus Fixed Fee pricing type. The contract does not have a set-aside designation. The contract is described as "TAS::75 0885::TAS", which likely refers to the task or service area, though the specific details are not provided. The...
This federal contract award is for a Phase 1 clinical trial protocol development, implementation, and research laboratory analysis task for a therapeutic against malaria. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Duke University for $40,257. This task is part of the Therapeutics Against Infectious Diseases Phase 1 contract vehicle, which is a larger program supporting the development of therapeutics against infectious...